| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BERKSHIRE HATHAWAY INC DEL | 50 | 7,000 | 0.00% | ||
| 2 | NEVRO CORP COM | 142 | 36,000 | 0.01% | Put | |
| 3 | ADAPTIMMUNE THERAPEUTICS PLC | 7,691 | 63,000 | 0.02% | ||
| 4 | Nivalis Therapeutics Inc | 30,000 | 125,000 | 0.05% | ||
| 5 | Natera, Inc. | 31,693 | 302,000 | 0.11% | ||
| 6 | ALLSCRIPTS HEALTHCARE SOLUTN | 48,000 | 634,000 | 0.23% | ||
| 7 | BioPharmX Corporation | 700,636 | 764,000 | 0.28% | ||
| 8 | MANNKIND CORP. | 4,385 | 899,000 | 0.33% | Put | |
| 9 | MASIMO CORP | 25,900 | 1,084,000 | 0.39% | ||
| 10 | CYTRX CORP | 513,092 | 1,375,000 | 0.50% | ||
| 11 | INVUITY INC | 212,808 | 1,536,000 | 0.56% | ||
| 12 | ACCELERATE DIAGNOSTICS INC | 117,176 | 1,684,000 | 0.61% | ||
| 13 | LIPOCINE INC NEW | 240,438 | 2,440,000 | 0.89% | ||
| 14 | REGENXBIO INC COM | 241,323 | 2,606,000 | 0.95% | ||
| 15 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 190,981 | 3,029,000 | 1.10% | ||
| 16 | CORIUM INTERNATIONAL INC | 828,332 | 3,197,000 | 1.16% | ||
| 17 | CELLDEX THERAPEUTICS INC NEW | 989,376 | 3,740,000 | 1.36% | ||
| 18 | ISHARES 20 YEAR TREASURY BOND ETF | 30,000 | 3,918,000 | 1.42% | ||
| 19 | BIOCRYST PHARMACEUTICALS | 1,973,932 | 5,586,000 | 2.03% | ||
| 20 | BRISTOL MYERS SQUIBB CO | 109,701 | 7,008,000 | 2.54% | ||
| 21 | Atara Biotherapeutics Inc | 473,126 | 9,004,000 | 3.27% | ||
| 22 | SYMMETRY SURGICAL INC | 919,680 | 9,068,000 | 3.29% | ||
| 23 | MIRATI THERAPEUTICS INC COM | 428,457 | 9,169,000 | 3.33% | ||
| 24 | FIVE PRIME THERAPEUTICS INC | 226,998 | 9,223,000 | 3.35% | ||
| 25 | BLUEBIRD BIO INC COM | 226,371 | 9,621,000 | 3.49% | ||
| 26 | AGENUS INC | 2,414,524 | 10,044,000 | 3.65% | ||
| 27 | DICERNA PHARMACEUTICALS INC | 2,026,894 | 10,864,000 | 3.94% | ||
| 28 | AVEXIS INC COM | 473,374 | 12,895,000 | 4.68% | ||
| 29 | OMEROS CORP | 891,522 | 13,676,000 | 4.97% | ||
| 30 | KITE PHARMA INCORPORATED | 343,503 | 15,770,000 | 5.73% | ||
| 31 | ACHILLION PHARMACEUTICALS IN | 2,558,859 | 19,754,000 | 7.17% | ||
| 32 | LA JOLLA PHARMACEUTICAL CO | 1,169,065 | 24,445,000 | 8.87% | ||
| 33 | INCYTE CORP | 379,415 | 27,496,000 | 9.98% | ||
| 34 | ALNYLAM PHARMACEUTICALS INC | 866,379 | 54,383,000 | 19.74% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-16-009638, filed 2016.05.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
